Dolby Laboratories DLB

58.56 1.00 1.74% as of 25 Sep
Market cap
$5.4B
P/E
24.6×
Growth Flags show if company had growth for consecutive years

Insider Decisions

Total sells 15.94
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell 1 4 5 — 3 — 1 4 1 1 5 1
Insider Ownership 38.14%

Capital & Financial Ratios

Market Cap 5,380.00
Revenue 1,354.36
Net Income 228.00
Free Cash Flow 361.13
Net Debt (739.54)
Current Ratio 3.19
Debt/Equity 0.00
P/E ratio 24.61
P/S ratio 4.07
P/B ratio 2.13
Past 5Y EPS Growth 1.97%
This Y EPS Growth 1.92%
Next Y EPS Growth 5.99%
Next 5Y EPS Growth 6.35%
in millions of $

Dividends

Payout Ratio 0.47
Annual Dividend Rate 1.08
Annual Dividend Yield 1.38%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 1.36
0.36
0.36
0.36
2025 1.35
0.33
0.33
0.33
0.36
2024 1.23
0.30
0.30
0.30
0.33
2023 1.11
0.27
0.27
0.27
0.30
2022 1.02
0.25
0.25
0.25
0.27
2021 0.91
0.22
0.22
0.22
0.25
2020 0.88
0.22
0.22
0.22
0.22
2019 0.79
0.19
0.19
0.19
0.22
2018 0.67
0.16
0.16
0.16
0.19
2017 0.58
0.14
0.14
0.14
0.16
2016 0.50
0.12
0.12
0.12
0.14
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 957 578 794 740
Receivables 262 315 331 285
Inventory 36 34 30 31
Other 182 197 181 207
1,488 1,194 1,388 1,326
2023 2024 2025 Q'26
Payables 21 17 18 12
ST’ Debt — — — —
Other 32 32 31 34
422 418 438 416
in millions of $

Compound Annual Growth

10y 5y 3y
Sales 3.35% 3.04% 2.47%
Cash Flow 4.32% 6.55% 14.02%
Earnings 3.47% 1.97% 11.48%
Book Value 3.78% 1.54% 5.35%

Revenue

Dec Mar Jun Sep Year
’26 347 396 305 — —
’25 357 370 316 307 1,349
’24 316 365 289 305 1,274
’23 335 376 298 291 1,300
’22 352 334 290 278 1,254
’21 390 320 287 285 1,281
’20 292 352 247 271 1,162
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Dec Mar Jun Sep Year
’26 55 93 167 — —
’25 107 175 68 123 472
’24 8 181 21 116 327
’23 56 105 121 85 367
’22 32 63 173 51 319
’21 82 83 172 110 448
’20 31 66 134 113 344
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Dec Mar Jun Sep Year
’26 56 46 158 — —
’25 100 168 61 101 430
’24 2 172 14 109 297
’23 49 97 114 77 337
’22 6 51 161 41 259
’21 83 70 159 98 410
’20 7 45 120 102 275
in millions of $ · fiscal quarters ending in the months shown

EPS

Dec Mar Jun Sep Year
’26 0.55 0.99 0.30 — —
’25 0.70 0.94 0.48 0.51 2.62
’24 0.69 1.01 0.40 0.61 2.69
’23 0.82 0.98 0.17 0.09 2.05
’22 0.77 0.36 0.39 0.28 1.81
’21 1.30 0.73 0.52 0.42 2.97
’20 0.47 0.86 0.66 0.26 2.25
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1.5
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
30.38 45.13 58.17 56.09 44.68 83.10 61.55 70.26 66.35 64.02

Analyst estimates 2026–2028

Powerpack
Low Price
55.02 63.34 74.29 70.17 97.50 104.74 96.85 91.02 86.37 89.66
High Price
2,030 2,122 2,151 2,193 2,289 2,368 2,336 2,246 2,080 2,051
Employees
1 1 0 1 1 1 1 1 1 1
Revenue/Emp
1,026 1,080 1,055 1,242 1,162 1,281 1,254 1,300 1,274 1,349
Revenue
89.38% 89.03% 87.90% 87.04% 87.39% 89.85% 88.73% 88.26% 88.97% 88.13%
Gross Margin
236 255 196 282 240 355 215 250 312 303
EBT
23.00% 23.62% 18.62% 22.74% 20.63% 27.67% 17.17% 19.24% 24.53% 22.49%
EBT Margin
186 207 42 256 232 318 184 202 264 256
Net Income
89 87 84 85 113 114 105 95 84 99
Depreciation
10.18 10.61 10.20 12.22 11.55 12.66 12.54 13.57 13.33 14.07
Revenue/Sh
1.85 1.98 0.41 2.51 2.30 3.07 1.84 2.10 2.74 2.66
Earnings/Sh
3.58 3.71 3.41 3.22 3.42 4.42 3.19 3.83 3.43 4.93
Cash Flow/Sh
(2.20) (1.03) (0.83) (1.12) (0.69) (0.38) (0.59) (0.32) (0.31) (0.44)
Capex/Sh
1.37 2.68 2.58 2.11 2.73 4.05 2.59 3.52 3.11 4.49
Free CF/Sh
19.65 21.06 22.93 22.76 24.25 25.74 22.51 24.77 26.03 27.45
Book Value/Sh
101 102 103 102 101 101 100 96 96 96
Shares
29.35 29.08 150.83 25.75 28.69 28.66 35.41 38.43 28.03 27.21
PE Ratio
5.33 5.45 6.79 5.29 5.74 6.95 5.20 5.95 5.74 5.14
PS Ratio
2.76 2.75 3.02 2.84 2.73 3.42 2.89 3.26 2.94 2.64
PB Ratio
4.71 4.64 5.75 4.55 4.77 5.96 4.54 5.21 5.29 4.55
EV/Sales
34.90 18.35 22.71 26.36 20.15 18.75 21.99 20.82 23.57 14.28
EV/FCF
360 378 352 328 344 448 319 367 327 472
Op' Cash Flow
(222) (105) (85) (114) (69) (38) (59) (30) (30) (42)
Capex
138 273 267 214 275 410 259 337 297 430
FCF
547 766 1,211 1,075 1,280 1,445 1,033 1,066 777 950
Working Cap'
— — — — 81 72 51 51 — —
Total Debt
(641) (882) (1,103) (925) (1,127) (1,272) (818) (957) (578) (794)
Net Debt
1,979 2,144 2,371 2,313 2,438 2,604 2,251 2,372 2,487 2,632
Sh' Equity
8.37% 8.53% 1.55% 8.97% 8.06% 10.30% 6.35% 7.08% 8.60% 8.05%
ROA
10.83% 12.24% 9.05% 11.57% 10.42% 16.16% 9.01% 9.53% 8.46% 9.01%
ROIC
9.80% 10.02% 1.85% 10.90% 9.74% 12.30% 7.58% 8.68% 10.78% 9.96%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Sep 2025 · latest quarter Jun 2026

Dolby Laboratories peers in Specialty Business Services

All 44 Specialty Business Services stocks →

Dolby Laboratories (DLB) key facts

  • Dolby Laboratories (DLB) is a Specialty Business Services company in the Industrials sector, listed on the New York Stock Exchange.
  • Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024.
  • Net income was $256.5 million, or $2.66 per share (basic), a net margin of 18.9%.
  • As of September 25, 2026, DLB traded at $58.56, a market capitalization of $5.4 billion.
  • At that price the stock trades at 24.6× trailing-twelve-month earnings and 4.1× sales.
  • Dolby Laboratories pays an annual dividend of $1.08 per share, a yield of 1.38%, with a payout ratio of 47.1%.
  • Return on equity was 9.96% and debt-to-equity 0.00.

Source: company filings (standardised) and stockrow calculations.

Dolby Laboratories (DLB) Latest News

News by impact score

Fine-tune

25 Sep

4

Dolby Laboratories (DLB) returns to investor focus as Meta extends Dolby Atmos and Dolby Vision across Meta AI glasses, Instagram, and a future VR headset, widening Dolby’s role in consumer hardware and social platforms. Shares have weakened, with 30-day return -12.95%, YTD -9.4%, and 1-year TSR -17.52%. The piece urges scanning for similar partnerships across other audio/video platforms, listing 16 undiscovered gems. Analysts see upside from usage-based licensing and higher-margin formats, with a fair value around $79 vs. $57.56 today. Growth in Atmos, Vision, and imaging patents could lift licensing revenue ~15% YoY and near half of licensing revenue by FY26, helping margins. Risks include higher component costs for low-end devices and content or automotive royalties not scaling as modeled. Investors are asked to weigh four rewards against one warning sign. Expansion of cross-platform Meta deal could meaningfully boost Dolby's licensing revenue and margins.

24 Sep

4

Meta and Dolby Laboratories announced that Meta AI glasses will capture audio in Dolby Atmos and expand Dolby Vision experiences across Instagram and Meta’s upcoming VR headset, deepening Dolby’s role in social, AR, and VR media. The move broadens Dolby’s formats beyond cinema and home entertainment into everyday content creation and sharing inside one of the world’s largest consumer ecosystems. Dolby’s investment narrative now hinges on continued relevance of premium audio and video formats as media shifts to streaming and immersive platforms. While the deal strengthens Dolby’s footprint via Meta, near-term concerns remain about muted revenue growth and margin pressure. Dolby OptiView’s updates—adding Dolby Vision and AI-powered Sports Intelligence—plus the Meta tie-in represent potential growth vectors, but their ability to offset rising expenses and weaker legacy licensing momentum is still uncertain. Projections imply moderate growth to 2029 with upside if adoption scales. Expansion into Meta's social/AR/VR ecosystem could meaningfully expand Dolby's addressable market beyond cinema, potentially altering growth trajectory.

4

Dolby Laboratories expands Atmos and Dolby Vision across Meta Platforms' ecosystem, extending the tech to Meta AI glasses, Instagram and Meta's forthcoming VR devices. Meta AI glasses will be capable of capturing Dolby Atmos audio for Instagram moments, while Dolby Vision remains available on Instagram and other platforms. The expansion also broadens support to new device categories, including smart glasses and video cameras, and Meta’s next VR device will launch with Dolby Vision and Dolby Atmos. Dolby says Atmos, Vision and imaging-patent revenue could rise about 15% year over year in fiscal 2026, boosted by wider adoption. Meta became a licensee of Dolby’s video distribution patent program, with about 45 licensors in its first year. Competitors cited include Sony and Sonos, underscoring Dolby’s expanding reach in consumer devices and content experiences. Deepens Dolby's consumer-device ecosystem and revenue potential by integrating Atmos/Vision across Meta's popular platforms and upcoming devices.

4

Dolby Laboratories (DLB) and Meta Platforms (META) said they’re expanding Dolby Atmos and Dolby Vision throughout Meta’s ecosystem. Meta’s new AI glasses will be the first global consumer device capable of capturing audio in Dolby Atmos, enabling spatial audio recording and sharing on Instagram, which already supports Dolby Vision. The effort builds on Instagram’s Dolby Vision rollout last year and extends Dolby’s presence across Meta’s social, wearable, and VR platforms. Meta also said its upcoming VR device will support Dolby Vision and Dolby Atmos at launch next year, in tandem with Connect 2026’s unveiling of a $1,299 VR glasses device and a broader Muse AI rollout. Dolby’s collaboration with Meta could boost Dolby Atmos/Vision adoption across consumer devices and experiences, potentially benefiting Dolby’s licensing revenue and product penetration. Expanding Atmos/Vision across Meta devices creates a meaningful growth opportunity for Dolby's licensing and adoption.

3

September 2026 sees EssilorLuxottica, Meta, and Dolby broaden Meta's wearables ecosystem with over 100 Ray-Ban Meta AI and Audio styles, adding Dolby Atmos capture and Dolby Vision/Atmos support to Instagram and a forthcoming VR device. Muse, Meta's personal AI agent, runs on these AI glasses, turning eyewear into a hands-free compute interface that links AI, commerce, and entertainment to Meta's hardware footprint. Near-term revenues hinge on Muse uptake, while heavy AI capex for Reality Labs remains the main margin and free-cash-flow risk. The Dolby–Ray-Ban collaboration expands Atmos-enabled glasses but doesn't fundamentally alter the risk-reward balance in the near term. If adoption accelerates, it could bolster Muse-focused commerce and expand Dolby's wearables revenue, though AI capex and regulation keep upside constrained. Expands Dolby's exposure to AR wearables and AI-enabled ecosystems, offering potential revenue lift but not resolving margin pressures.

23 Sep

4

Dolby Laboratories and Meta expand Dolby Atmos and Dolby Vision across Meta's ecosystem, enabling new experiences on Meta AI glasses, Instagram, and future VR devices. Meta AI glasses will be the first global consumer device capable of capturing audio in Dolby Atmos, letting users capture moments and share them on Instagram with enhanced immersion. Dolby Vision has already expanded to Instagram; Atmos and Vision will now span more Meta platforms. Meta's upcoming VR device will support Dolby Vision and Dolby Atmos, delivering more immersive movies, shows, sports, concerts, and premium VR experiences when it launches next year. Dolby says the goal is deeper emotional engagement across creation, sharing, and consumption. Expansion into Meta's vast consumer ecosystem could meaningfully boost Dolby's licensing revenue and adoption of Atmos/Vision.

15 Sep

3

Rising component costs and weak consumer spending threaten Dolby Laboratories' growth outlook. Rising component costs and weak consumer spending may pressure Dolby Laboratories financial performance.

10 Sep

3

Dolby Laboratories expands Dolby OptiView Platform with new capabilities announced at IBC 2026. Platform expansion adds new capabilities that support product innovation and may moderately affect competitive positioning.

27 Aug

4

Dolby Laboratories expands into in-car gaming and live sports streaming. Strategic expansion into in-car gaming and live sports streaming constitutes major move likely to alter company trajectory.

11 Aug

3

Dolby Laboratories acquired FAU video compression technology portfolio. Acquisition adds video compression technology to Dolby's portfolio.

8 Aug

4

Dolby Laboratories encounters a billion dollar setback that highlights major risks for investors in the company's operations and outlook. Billion dollar scale events signal major financial or strategic shifts likely to alter the company's trajectory.

6 Aug

4

Dolby Vision 2 launches on Hisense TVs as Dolby's most advanced picture technology. Hisense TV rollout expands Dolby Vision 2 adoption and strengthens core AV technology positioning.

3 Aug

3

Dolby Laboratories questions whether its fiscal Q4 growth outlook can overcome licensing volatility. Licensing volatility creates moderate risk to Dolby revenue stability and growth outlook.

3

Dolby Laboratories stock faces scrutiny over growth potential clashing with near-term execution risks that could affect buying decisions and performance outlook. Growth versus execution risks point to moderate effects on financial performance and investor sentiment without major trajectory shifts.

1 Aug

4

Dolby Laboratories raised buybacks and guidance. Stock rose 18 percent. Bull case for the company now under review after the updates. Raising buybacks and guidance constitutes major strategic moves that could significantly alter the company's trajectory and investor sentiment.

3

Dolby Laboratories Q3 results prompt assessment of whether stock appears fairly valued based on performance and market conditions. Q3 earnings and valuation review may moderately influence financial sentiment and short-term positioning but lack transformative elements.

31 Jul

4

Dolby Laboratories Inc reported strong licensing growth in its Q3 2026 earnings call. Strong licensing growth signals expanded revenue potential that can materially lift future results.

3

Dolby Laboratories Q2 results show patent licensing and automotive momentum offsetting softer device sales. Patent licensing and automotive momentum balance device sales weakness with moderate effect on future performance.

3 transcript

Dolby Laboratories Q3 earnings call highlighted financial results, licensing revenue trends, product adoption for Atmos and Vision, and forward guidance on partnerships and technology expansion. Q3 earnings call supplies updated financial metrics and strategic outlook that may shift near-term market sentiment without fundamentally redirecting long-term trajectory.

30 Jul

3 transcript

Dolby Laboratories, Inc. held its Q3 2026 earnings call covering quarterly financial results, business performance, and forward outlook. Quarterly earnings details and guidance can moderately shift investor sentiment and short-term valuation.

3 transcript

Dolby Laboratories held its Q3 2026 earnings call covering quarterly financial results, business performance, and forward outlook. Earnings call supplies quarterly financial metrics and strategy details that may shift near-term investor sentiment.

3

Dolby Laboratories reported Q3 earnings along with analysis of key metrics. Q3 earnings and metrics offer moderate insight into financial performance and investor sentiment.

3

Dolby Laboratories missed Q2 CY2026 sales expectations. Missing quarterly sales targets typically triggers short-term negative stock reactions and reduced investor sentiment.

3

Dolby Laboratories reported its third quarter 2026 financial results. Quarterly earnings releases typically drive moderate short-term shifts in valuation and sentiment.

16 Jul

3

Sony's entertainment strategy raises questions about supporting long-term growth, with potential effects on Dolby Laboratories' technology partnerships and market position in audio-visual entertainment. Sony strategy shifts may moderately influence Dolby revenue and competitive positioning in entertainment.

11 Jun

4

Dolby Laboratories secures World Cup deal underscoring its expanding role in premium streaming standards. World Cup partnership strengthens Dolby's streaming standards position with major visibility.

29 May

3

Dolby partners with rednote to integrate Dolby Atmos into video content for enhanced immersive storytelling. Partnership expands Dolby Atmos adoption in video production with moderate effect on innovation and positioning.

4 May

4 transcript

Dolby Laboratories (DLB) released Q3 2025 earnings call transcript detailing financial results, revenue growth, profitability, and strategic updates on audio, imaging, and licensing segments. Q3 2025 earnings transcript discloses financial performance and guidance that significantly influence DLB's valuation and investor outlook.

3

Dolby Laboratories beat Q2 earnings estimates with mixed results but issued softer forward guidance, prompting a valuation reassessment amid concerns over future growth. Mixed Q2 beat tempered by softer guidance will moderately affect financial performance and investor sentiment without fundamentally altering long-term trajectory.

3 May

3

Dolby Laboratories' Q1 results show mixed guidance, with an expanding ecosystem shaping the company's future outlook. Mixed Q1 guidance offsets ecosystem expansion, creating moderate influence on financial performance and investor sentiment.

stockrow.com/DLB · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com